DNA plasmid that codes for human Bcl-2 gene preserves axotomized Clarke's nucleus neurons and reduces atrophy after spinal cord hemisection in adult rats
K. Takahashi et al., DNA plasmid that codes for human Bcl-2 gene preserves axotomized Clarke's nucleus neurons and reduces atrophy after spinal cord hemisection in adult rats, J COMP NEUR, 404(2), 1999, pp. 159-171
Spinal cord injury in adult mammals causes atrophy or death of some axotomi
zed neurons. The product of the antiapoptotic gene Bcl-2 prevents neuron de
ath in vivo. We delivered Bcl-2 by intraspinal injection of a DNA plasmid e
ncoding this gene to determine if axotomized neurons destined to undergo re
trograde death could be rescued. Axons of the right side Clarke's Nucleus (
CN) were cut unilaterally in adult Sprague-Dawley rats by T8 hemisection, l
eaving the contralateral (left) CN as an intact control. Two months postope
ratively, there was similar to 35% loss of total CN neurons in the right L1
segment. Only 15% of large CN neurons (>400 mu m(2)), whose axons project
to the cerebellum, survived-indicating atrophy and/or death of 85% of these
cells. We injected a DNA plasmid encoding the human Bcl-2 gene and the bac
terial reporter gene LacZ, which was complexed with cationic lipids, into t
he right side of segment T8 of the normal spinal cord, or just caudal to th
e hemisection site. The reporter gene was expressed in the perikarya of rig
ht CN neurons at LI for up to 7 days, but not 14 days. Two months following
T8 hemisection and Bcl-2/LacZ DNA injection, there was no significant loss
of CN neurons ipsilateral to the lesion. Surprisingly, 61% of large neuron
s survived, indicating partial protection from atrophy. In contrast, a DNA
plasmid that codes for the LacZ reporter gene, but not Bcl-2, did not preve
nt CN neuron death or atrophy. Administration of the Bcl-2 gene in adult ra
ts and its expression in these CNS neurons prevents retrograde cell. death,
and also minimizes atrophy. These results may serve as the basis for devel
oping novel gene therapy strategies for patients with spinal cord injury. (
C) 1999 Wiley-Liss, Inc.